These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8621590)

  • 1. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling.
    Beitner-Johnson D; Blakesley VA; Shen-Orr Z; Jimenez M; Stannard B; Wang LM; Pierce J; LeRoith D
    J Biol Chem; 1996 Apr; 271(16):9287-90. PubMed ID: 8621590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplastic transformation induced by insulin receptor substrate-1 overexpression requires an interaction with both Grb2 and Syp signaling molecules.
    Tanaka S; Ito T; Wands JR
    J Biol Chem; 1996 Jun; 271(24):14610-6. PubMed ID: 8662827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor-I stimulates tyrosine phosphorylation of endogenous c-Crk.
    Beitner-Johnson D; LeRoith D
    J Biol Chem; 1995 Mar; 270(10):5187-90. PubMed ID: 7534289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling.
    Kim B; Cheng HL; Margolis B; Feldman EL
    J Biol Chem; 1998 Dec; 273(51):34543-50. PubMed ID: 9852124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine residues in the C-terminal domain of the insulin-like growth factor-I receptor mediate mitogenic and tumorigenic signals.
    Esposito DL; Blakesley VA; Koval AP; Scrimgeour AG; LeRoith D
    Endocrinology; 1997 Jul; 138(7):2979-88. PubMed ID: 9202243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-like growth factor I receptor-induced interaction of insulin receptor substrate-4 and Crk-II.
    Karas M; Koval AP; Zick Y; LeRoith D
    Endocrinology; 2001 May; 142(5):1835-40. PubMed ID: 11316748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4PS/insulin receptor substrate (IRS)-2 is the alternative substrate of the insulin receptor in IRS-1-deficient mice.
    Patti ME; Sun XJ; Bruening JC; Araki E; Lipes MA; White MF; Kahn CR
    J Biol Chem; 1995 Oct; 270(42):24670-3. PubMed ID: 7559579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the insulin and insulin-like growth factor 1 mitogenic intracellular signaling pathways.
    Sasaoka T; Ishiki M; Sawa T; Ishihara H; Takata Y; Imamura T; Usui I; Olefsky JM; Kobayashi M
    Endocrinology; 1996 Oct; 137(10):4427-34. PubMed ID: 8828504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation-dependent and -independent role of Shc in the regulation of IGF-1-induced mitogenesis and glycogen synthesis.
    Sasaoka T; Ishiki M; Wada T; Hori H; Hirai H; Haruta T; Ishihara H; Kobayashi M
    Endocrinology; 2001 Dec; 142(12):5226-35. PubMed ID: 11713219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
    Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
    Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin receptor substrate-1-related 4PS substrate but not the interleukin-2R gamma chain is involved in interleukin-13-mediated signal transduction.
    Wang LM; Michieli P; Lie WR; Liu F; Lee CC; Minty A; Sun XJ; Levine A; White MF; Pierce JH
    Blood; 1995 Dec; 86(11):4218-27. PubMed ID: 7492780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    Brüning JC; Winnay J; Cheatham B; Kahn CR
    Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells.
    Wang LM; Keegan AD; Li W; Lienhard GE; Pacini S; Gutkind JS; Myers MG; Sun XJ; White MF; Aaronson SA
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4032-6. PubMed ID: 7683417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin receptor substrate-4 enhances insulin-like growth factor-I-induced cell proliferation.
    Qu BH; Karas M; Koval A; LeRoith D
    J Biol Chem; 1999 Oct; 274(44):31179-84. PubMed ID: 10531310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the Shb SH2 domain-protein in insulin-producing cells leads to altered signaling through the IRS-1 and IRS-2 proteins.
    Welsh N; Makeeva N; Welsh M
    Mol Med; 2002 Nov; 8(11):695-704. PubMed ID: 12520086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation.
    Lingohr MK; Dickson LM; McCuaig JF; Hugl SR; Twardzik DR; Rhodes CJ
    Diabetes; 2002 Apr; 51(4):966-76. PubMed ID: 11916914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulin-like growth factor receptor in 3T3-L1 adipocytes.
    Ursø B; Cope DL; Kalloo-Hosein HE; Hayward AC; Whitehead JP; O'Rahilly S; Siddle K
    J Biol Chem; 1999 Oct; 274(43):30864-73. PubMed ID: 10521479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine 1-phosphate stimulates tyrosine phosphorylation of Crk.
    Blakesley VA; Beitner-Johnson D; Van Brocklyn JR; Rani S; Shen-Orr Z; Stannard BS; Spiegel S; LeRoith D
    J Biol Chem; 1997 Jun; 272(26):16211-5. PubMed ID: 9195921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.
    Tsuruzoe K; Emkey R; Kriauciunas KM; Ueki K; Kahn CR
    Mol Cell Biol; 2001 Jan; 21(1):26-38. PubMed ID: 11113178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction in vitro of the product of the c-Crk-II proto-oncogene with the insulin-like growth factor I receptor.
    Koval AP; Blakesley VA; Roberts CT; Zick Y; Leroith D
    Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):923-32. PubMed ID: 9480911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.